Stem Cell Therapy for Multiple Myeloma
LYMPHOMAS
What is Stem Cell Therapy in Multiple Myeloma?
Multiple myeloma is a cancer of plasma cells, a type of white blood cell crucial for antibody production. It primarily affects bones and kidneys.
Causes of Multiple Myeloma that need Stem Cell Therapy
The precise cause of multiple myeloma is unknown. It develops when plasma cells mutate in their DNA, causing them to grow and divide uncontrollably. These abnormal cells accumulate in bone marrow, forming tumors that can spread and affect various organs.
Multiple myeloma primarily affects the bone marrow, where abnormal plasma cells interfere with the production of healthy blood cells. This can lead to anemia, increased risk of infections, and bone damage. As the disease progresses, it often results in bone lesions, causing pain, fractures, and weakened bones. The excessive accumulation of myeloma cells also disrupts the body’s ability to produce normal antibodies, leaving the patient vulnerable to infections.
Treatment options for multiple myeloma have advanced significantly in recent years. Standard treatments include chemotherapy, immunotherapy, and targeted therapies that focus on inhibiting the growth of cancer cells. Additionally, stem cell transplants are often used to restore healthy bone marrow after aggressive treatments. While there is no cure for multiple myeloma, ongoing research into new therapies continues to improve survival rates and quality of life for patients.
Symptoms of Multiple Myeloma that need Stem Cell Therapy
- Bone pain, especially in the spine or chest
- Nausea
- Constipation
- Loss of appetite
- Cognitive difficulties
- Chronic fatigue
- Frequent infections
- Weight loss
Types of Multiple Myeloma
Multiple myeloma is categorized based on the type of abnormal protein produced. This classification guides treatment. Types include:
Smoldering multiple myeloma
Early-stage, asymptomatic myeloma.
Active multiple myeloma
Symptomatic myeloma requiring treatment.